|
|
|
Insider
Information: |
Maraganore John |
Relationship: |
Director |
City: |
Cambridge |
State: |
MA |
|
|
Insider
Summary: |
|
|
|
Companies Owned : |
4 |
|
Direct
Shares |
263,534 |
|
Indirect Shares
|
6,153,633 |
|
|
Direct
Value |
$35,430,768 |
|
|
Indirect Value
|
$14,183,372 |
|
|
Total
Shares |
6,417,167 |
|
|
Total
Value |
$49,614,140 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
Total
Filings :
|
0
|
0
|
Stock
price went up :
|
0
|
0
|
Stock
price went down : |
0
|
0
|
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
Percentage
Gain/Loss : |
0.0%
|
0.0%
|
|
|
|
|
|
|
Holdings
:
Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold |
|
Alnylam Pharmaceuticals Inc |
ALNY |
Chief Executive Office... |
2021-12-22 |
227,663 |
2021-12-22 |
3,133 |
Premium* |
|
Regulus Therapeutics Inc. |
RGLS |
Director, 10% Owner |
2012-10-10 |
0 |
2012-10-10 |
6,150,500 |
Premium* |
|
Agios Pharmaceuticals Inc |
AGIO |
Director |
2022-05-20 |
30,028 |
|
0 |
Premium* |
|
Bluebird Bio, Inc. |
BLUE |
Director |
2017-09-14 |
5,843 |
2014-07-14 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
Records found :
154 |
Free Registration Required For Full Results. Limit: 25
|
|
Download |
Page 5 of 7
|
Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
ALNY |
Alnylam Pharmaceuticals I... |
Chief Executive Officer |
|
2020-08-20 |
4 |
AS |
$135.09 |
$4,732,542 |
D/D |
(34,765) |
197,589 |
0 |
% |
|
ALNY |
Alnylam Pharmaceuticals I... |
Chief Executive Officer |
|
2020-08-20 |
4 |
OE |
$9.14 |
$317,752 |
D/D |
34,765 |
232,354 |
0 |
- |
|
ALNY |
Alnylam Pharmaceuticals I... |
Chief Executive Officer |
|
2020-11-19 |
4 |
OE |
$9.14 |
$317,752 |
D/D |
34,765 |
232,354 |
0 |
- |
|
ALNY |
Alnylam Pharmaceuticals I... |
Chief Executive Officer |
|
2020-11-19 |
4 |
AS |
$123.55 |
$4,319,025 |
D/D |
(34,765) |
197,589 |
0 |
% |
|
ALNY |
Alnylam Pharmaceuticals I... |
President & CEO |
|
2006-05-12 |
4 |
OE |
$0.48 |
$17,813 |
D/D |
37,500 |
46,770 |
|
- |
|
ALNY |
Alnylam Pharmaceuticals I... |
CEO |
|
2007-06-28 |
4 |
OE |
$0.48 |
$17,813 |
D/D |
37,500 |
37,500 |
0 |
- |
|
ALNY |
Alnylam Pharmaceuticals I... |
CEO |
|
2007-06-29 |
4 |
OE |
$0.48 |
$17,813 |
D/D |
37,500 |
37,500 |
0 |
- |
|
ALNY |
Alnylam Pharmaceuticals I... |
CEO |
|
2008-08-13 |
4 |
OE |
$0.48 |
$17,813 |
D/D |
37,500 |
37,500 |
0 |
- |
|
ALNY |
Alnylam Pharmaceuticals I... |
CEO |
|
2008-08-13 |
4 |
AS |
$33.95 |
$1,273,005 |
D/D |
(37,500) |
0 |
0 |
- |
|
ALNY |
Alnylam Pharmaceuticals I... |
CEO |
|
2008-08-14 |
4 |
OE |
$0.48 |
$17,813 |
D/D |
37,500 |
37,500 |
0 |
- |
|
ALNY |
Alnylam Pharmaceuticals I... |
CEO |
|
2008-08-14 |
4 |
AS |
$34.23 |
$1,283,512 |
D/D |
(37,500) |
0 |
0 |
- |
|
ALNY |
Alnylam Pharmaceuticals I... |
CEO |
|
2009-06-16 |
4 |
OE |
$0.48 |
$19,000 |
D/D |
40,000 |
400 |
0 |
- |
|
ALNY |
Alnylam Pharmaceuticals I... |
CEO |
|
2009-06-16 |
4 |
AS |
$21.43 |
$857,590 |
D/D |
(40,000) |
0 |
0 |
- |
|
ALNY |
Alnylam Pharmaceuticals I... |
CEO |
|
2009-06-17 |
4 |
OE |
$0.48 |
$19,000 |
D/D |
40,000 |
40,000 |
0 |
- |
|
ALNY |
Alnylam Pharmaceuticals I... |
CEO |
|
2009-06-17 |
4 |
AS |
$21.40 |
$855,840 |
D/D |
(40,000) |
0 |
0 |
- |
|
ALNY |
Alnylam Pharmaceuticals I... |
CEO |
|
2009-06-18 |
4 |
OE |
$0.48 |
$19,000 |
D/D |
40,000 |
28,200 |
0 |
- |
|
ALNY |
Alnylam Pharmaceuticals I... |
CEO |
|
2009-06-18 |
4 |
AS |
$21.37 |
$854,648 |
D/D |
(40,000) |
0 |
0 |
- |
|
ALNY |
Alnylam Pharmaceuticals I... |
CEO |
|
2014-02-03 |
4 |
OE |
$6.78 |
$314,124 |
D/D |
46,331 |
77,613 |
0 |
- |
|
ALNY |
Alnylam Pharmaceuticals I... |
Chief Executive Officer |
|
2019-10-14 |
4 |
AS |
$78.92 |
$3,929,210 |
D/D |
(49,456) |
189,993 |
0 |
- |
|
ALNY |
Alnylam Pharmaceuticals I... |
Chief Executive Officer |
|
2019-10-14 |
4 |
OE |
$16.43 |
$812,562 |
D/D |
49,456 |
239,449 |
0 |
- |
|
ALNY |
Alnylam Pharmaceuticals I... |
Chief Executive Officer |
|
2019-05-15 |
4 |
OE |
$16.43 |
$812,579 |
D/D |
49,457 |
239,450 |
0 |
- |
|
ALNY |
Alnylam Pharmaceuticals I... |
Chief Executive Officer |
|
2019-05-15 |
4 |
AS |
$70.00 |
$3,461,990 |
D/D |
(49,457) |
189,993 |
0 |
- |
|
ALNY |
Alnylam Pharmaceuticals I... |
CEO |
|
2010-08-17 |
4 |
OE |
$0.48 |
$23,750 |
D/D |
50,000 |
50,000 |
0 |
- |
|
ALNY |
Alnylam Pharmaceuticals I... |
Chief Executive Officer |
|
2018-07-25 |
4 |
OE |
$21.35 |
$1,067,500 |
D/D |
50,000 |
201,297 |
0 |
- |
|
ALNY |
Alnylam Pharmaceuticals I... |
Chief Executive Officer |
|
2018-07-25 |
4 |
AS |
$102.51 |
$5,269,457 |
D/D |
(50,000) |
151,297 |
0 |
- |
|
154 Records found
|
|
Page 5 of 7 |
|
Free Registration Required For Full Results. Limit: 25
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|